Pyxis Oncology Files 8-K
Ticker: PYXS · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1782223
| Field | Detail |
|---|---|
| Company | Pyxis Oncology, Inc. (PYXS) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
Related Tickers: PYXS
TL;DR
Pyxis Oncology filed an 8-K, but details are scarce.
AI Summary
Pyxis Oncology, Inc. filed an 8-K on August 4, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates Pyxis Oncology has made a reportable event, but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and lacks specific material information that would immediately impact risk.
Key Players & Entities
- Pyxis Oncology, Inc. (company) — Registrant
- August 04, 2025 (date) — Date of earliest event reported
- 321 Harrison Avenue (location) — Principal Executive Offices Address
- Boston (location) — City of Principal Executive Offices
- Massachusetts (location) — State of Principal Executive Offices
- 02118 (location) — Zip Code of Principal Executive Offices
- (617) 453-3596 (phone_number) — Registrant's Telephone Number
FAQ
What specific event is Pyxis Oncology reporting in this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the exact nature of the event.
When was the earliest event reported in this filing?
The earliest event reported was on August 04, 2025.
What is the principal executive office address for Pyxis Oncology?
The principal executive offices are located at 321 Harrison Avenue, Boston, Massachusetts 02118.
What is the telephone number for Pyxis Oncology?
The registrant's telephone number, including area code, is (617) 453-3596.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Pyxis Oncology, Inc. (PYXS).